Predictors and outcomes of scleroderma renal crisis: data from the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial

Interobserver variability in synovial tissue biopsy markers in Rheumatoid Arthritis: Results from OMERACT special interest group on synovial tissue biopsy.

Seminars in arthritis and rheumatism·2026

Qualitative interview study in patients with SLE to assess patient perception of fatigue and skin-related symptoms.

Lupus science & medicine·2026

Development of a single‑item patient‑reported measure of treatment side‑effect burden in clinical trials of rheumatic and musculoskeletal diseases using stakeholder input and large language model refinement.

Seminars in arthritis and rheumatism·2026

Composite outcome measures that successfully differentiate active treatments from placebo in psoriatic arthritis trials: a GRAPPA-OMERACT systematic review and network meta-analysis.

Annals of the rheumatic diseases·2026

Olokizumab Improves Patient-Reported Outcomes in Patients with Active Rheumatoid Arthritis up to 106 Weeks (Results from the Open-Label Extension of Phase III Randomized Clinical Trials).

Rheumatology and therapy·2026

Upadacitinib monotherapy versus methotrexate monotherapy in methotrexate-naïve Japanese patients with rheumatoid arthritis: Long-term efficacy and safety through 5 years in the SELECT-EARLY study.

Modern rheumatology·2026

Regional distribution of adult rheumatologists.

Arthritis and rheumatism·2013

Clinically significant renal involvement in primary Sjögren's syndrome: clinical presentation and outcome.

Arthritis and rheumatism·2013

Headache in systemic lupus erythematosus: results from a prospective, international inception cohort study.

Arthritis and rheumatism·2013

Association of low baseline levels of erythrocyte folate with treatment nonresponse at three months in rheumatoid arthritis patients receiving methotrexate.

Arthritis and rheumatism·2013

2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.

Arthritis and rheumatism·2013

Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1γ.

Arthritis and rheumatism·2013

A retrospective evaluation of antibiotic prescribing for recurrent urinary tract infection prophylaxis in adults in general practice.

Family practice·2026

Combined detection of HLA-B27, ESR, and CRP as biochemical and immunogenetic markers in the auxiliary diagnosis of ankylosing spondylitis.

Journal of medical biochemistry·2026

Biomarkers in axial spondyloarthritis diagnosis: from clinical signs to multi-omics integration.

Frontiers in immunology·2026

Real-world drug survival and treatment outcome of ixekizumab in patients with spondyloarthropathies.

Frontiers in immunology·2026

A case report of sporadic Creutzfeldt-Jakob disease presenting with progressive opsoclonus-myoclonus-ataxia-Plus (OMAS-Plus) phenotype.

Prion·2026

Time to redefine serum uric acid levels in women: A call for sex-specific cardiometabolic risk thresholds.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2026

Related Experiment Videos

Predictors and outcomes of scleroderma renal crisis: data from the high-dose versus low-dose D-penicillamine in early

Related Concept Videos

Interobserver variability in synovial tissue biopsy markers in Rheumatoid Arthritis: Results from OMERACT special interest group on synovial tissue biopsy.

Qualitative interview study in patients with SLE to assess patient perception of fatigue and skin-related symptoms.

Development of a single‑item patient‑reported measure of treatment side‑effect burden in clinical trials of rheumatic and musculoskeletal diseases using stakeholder input and large language model refinement.

Composite outcome measures that successfully differentiate active treatments from placebo in psoriatic arthritis trials: a GRAPPA-OMERACT systematic review and network meta-analysis.

Olokizumab Improves Patient-Reported Outcomes in Patients with Active Rheumatoid Arthritis up to 106 Weeks (Results from the Open-Label Extension of Phase III Randomized Clinical Trials).

Upadacitinib monotherapy versus methotrexate monotherapy in methotrexate-naïve Japanese patients with rheumatoid arthritis: Long-term efficacy and safety through 5 years in the SELECT-EARLY study.

Regional distribution of adult rheumatologists.

Clinically significant renal involvement in primary Sjögren's syndrome: clinical presentation and outcome.

Headache in systemic lupus erythematosus: results from a prospective, international inception cohort study.

Association of low baseline levels of erythrocyte folate with treatment nonresponse at three months in rheumatoid arthritis patients receiving methotrexate.

2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.

Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1γ.

A retrospective evaluation of antibiotic prescribing for recurrent urinary tract infection prophylaxis in adults in general practice.

Combined detection of HLA-B27, ESR, and CRP as biochemical and immunogenetic markers in the auxiliary diagnosis of ankylosing spondylitis.

Biomarkers in axial spondyloarthritis diagnosis: from clinical signs to multi-omics integration.

Real-world drug survival and treatment outcome of ixekizumab in patients with spondyloarthropathies.

A case report of sporadic Creutzfeldt-Jakob disease presenting with progressive opsoclonus-myoclonus-ataxia-Plus (OMAS-Plus) phenotype.

Time to redefine serum uric acid levels in women: A call for sex-specific cardiometabolic risk thresholds.

Related Experiment Videos

Predictors and outcomes of scleroderma renal crisis: data from the high-dose versus low-dose D-penicillamine in early...

Related Concept Videos

Related Articles

Predictors and outcomes of scleroderma renal crisis: data from the high-dose versus low-dose D-penicillamine in early